80 related articles for article (PubMed ID: 24614587)
1. KSHV RTA abolishes NFκB responsive gene expression during lytic reactivation by targeting vFLIP for degradation via the proteasome.
Ehrlich ES; Chmura JC; Smith JC; Kalu NN; Hayward GS
PLoS One; 2014; 9(3):e91359. PubMed ID: 24614587
[TBL] [Abstract][Full Text] [Related]
2. KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.
Combs LR; Spires LM; Alonso JD; Papp B; Toth Z
J Virol; 2022 Jun; 96(12):e0010122. PubMed ID: 35604218
[TBL] [Abstract][Full Text] [Related]
3. KSHV RTA utilizes the host E3 ubiquitin ligase complex RNF20/40 to drive lytic reactivation.
Spires LM; Wind E; Papp B; Toth Z
J Virol; 2023 Nov; 97(11):e0138923. PubMed ID: 37888983
[TBL] [Abstract][Full Text] [Related]
4. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.
Hunte R; Alonso P; Thomas R; Bazile CA; Ramos JC; van der Weyden L; Dominguez-Bendala J; Khan WN; Shembade N
PLoS Pathog; 2018 Apr; 14(4):e1006968. PubMed ID: 29698475
[TBL] [Abstract][Full Text] [Related]
5. A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
Sakakibara S; Espigol-Frigole G; Gasperini P; Uldrick TS; Yarchoan R; Tosato G
Oncogene; 2013 Mar; 32(10):1223-32. PubMed ID: 22525270
[TBL] [Abstract][Full Text] [Related]
6. CRISPR screens identify novel regulators of cFLIP dependency and ligand-independent, TRAIL-R1-mediated cell death.
Kuehnle N; Osborne SM; Liang Z; Manzano M; Gottwein E
Cell Death Differ; 2023 May; 30(5):1221-1234. PubMed ID: 36801923
[TBL] [Abstract][Full Text] [Related]
7. Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.
Morales AE; Gumenick R; Genovese CM; Jang YY; Ouedraogo A; Ibáñez de Garayo M; Pannellini T; Patel S; Bott ME; Alvarez J; Mun SS; Totonchy J; Gautam A; Delgado de la Mora J; Chang S; Wirth D; Horenstein M; Dao T; Scheinberg DA; Rubinstein PG; Semeere A; Martin J; Godfrey CC; Moser CB; Matining RM; Campbell TB; Borok MZ; Krown SE; Cesarman E
PLoS Pathog; 2024 Jan; 20(1):e1011881. PubMed ID: 38190392
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-mediated NFκB degradation pathway.
Xu H; You M; Shi H; Hou Y
Cell Mol Immunol; 2015 Nov; 12(6):653-5. PubMed ID: 25345807
[TBL] [Abstract][Full Text] [Related]
9. The Itch ubiquitin ligase is required for KSHV RTA induced vFLIP degradation.
Chmura JC; Herold K; Ruffin A; Atuobi T; Fabiyi Y; Mitchell AE; Choi YB; Ehrlich ES
Virology; 2017 Jan; 501():119-126. PubMed ID: 27912080
[TBL] [Abstract][Full Text] [Related]
10. Identification of the Essential Role of Viral Bcl-2 for Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Liang Q; Chang B; Lee P; Brulois KF; Ge J; Shi M; Rodgers MA; Feng P; Oh BH; Liang C; Jung JU
J Virol; 2015 May; 89(10):5308-17. PubMed ID: 25740994
[TBL] [Abstract][Full Text] [Related]
11. Viral Bcl-2 Encoded by the Kaposi's Sarcoma-Associated Herpesvirus Is Vital for Virus Reactivation.
Gelgor A; Kalt I; Bergson S; Brulois KF; Jung JU; Sarid R
J Virol; 2015 May; 89(10):5298-307. PubMed ID: 25740992
[TBL] [Abstract][Full Text] [Related]
12. Generation of high-titre virus stocks using BrK.219, a B-cell line infected stably with recombinant Kaposi's sarcoma-associated herpesvirus.
Kati S; Hage E; Mynarek M; Ganzenmueller T; Indenbirken D; Grundhoff A; Schulz TF
J Virol Methods; 2015 Jun; 217():79-86. PubMed ID: 25736227
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication.
Brulois K; Toth Z; Wong LY; Feng P; Gao SJ; Ensser A; Jung JU
J Virol; 2014 Aug; 88(16):9335-49. PubMed ID: 24899205
[TBL] [Abstract][Full Text] [Related]
14. The Interplay between KSHV Infection and DNA-Sensing Pathways.
Han C; Gui C; Dong S; Lan K
Viruses; 2024 May; 16(5):. PubMed ID: 38793630
[TBL] [Abstract][Full Text] [Related]
15. Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors.
Pakjoo M; Ahmadi SE; Zahedi M; Jaafari N; Khademi R; Amini A; Safa M
Cell Commun Signal; 2024 Feb; 22(1):105. PubMed ID: 38331801
[TBL] [Abstract][Full Text] [Related]
16. RUNX3 inhibits KSHV lytic replication by binding to the viral genome and repressing transcription.
Ren P; Niu D; Chang S; Yu L; Ren J; Ma Y; Lan K
J Virol; 2024 Feb; 98(2):e0156723. PubMed ID: 38197631
[TBL] [Abstract][Full Text] [Related]
17. E3 Ubiquitin Ligases in Gammaherpesviruses and HIV: A Review of Virus Adaptation and Exploitation.
Oswald J; Constantine M; Adegbuyi A; Omorogbe E; Dellomo AJ; Ehrlich ES
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766341
[TBL] [Abstract][Full Text] [Related]
18. Liver X Receptor-Inducible Host E3 Ligase IDOL Targets a Human Cytomegalovirus Reactivation Determinant.
Mlera L; Collins-McMillen D; Zeltzer S; Buehler JC; Moy M; Zarrella K; Caviness K; Cicchini L; Tafoya DJ; Goodrum F
J Virol; 2023 Jul; 97(7):e0075823. PubMed ID: 37338407
[TBL] [Abstract][Full Text] [Related]
19. Protein Degradation by Gammaherpesvirus RTAs: More Than Just Viral Transactivators.
Combs LR; Combs J; McKenna R; Toth Z
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992439
[TBL] [Abstract][Full Text] [Related]
20. KSHV RTA antagonizes SMC5/6 complex-induced viral chromatin compaction by hijacking the ubiquitin-proteasome system.
Han C; Zhang D; Gui C; Huang L; Chang S; Dong L; Bai L; Wu S; Lan K
PLoS Pathog; 2022 Aug; 18(8):e1010744. PubMed ID: 35914008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
